[Federal Register Volume 60, Number 158 (Wednesday, August 16, 1995)]
[Notices]
[Page 42577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20313]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 95M-0119]


Chartex International plc; Premarket Approval of 
Femidom Female Condom; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of June 8, 1995 (60 FR 30310). 
The document announced the approval of the premarket approval 
application for the Femidom Female Condom. The document was 
published with some errors. This document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Marquita B. Steadman, Center for 
Devices and Radiological Health (HFZ-84), Food and Drug Administration, 
2098 Gaither Rd., Rockville, MD 20850, 301-594-4765.
    In FR Doc. 95-14059, appearing on page 30310 in the Federal 
Register of Thursday, June 8, 1995, the following corrections are made: 
On page 30310, in the second column, under the SUMMARY caption, in the 
fourth line, and under the SUPPLEMENTARY INFORMATION caption, in the 
second line, insert ``Rhys, Bryant, U.S. representative for'' before 
``Chartex International plc, London, U. K.,''.

    Dated: August 8, 1995.
Joseph A. Levitt,
Deputy Director for Regulations Policy, Center for Devices and 
Radiological Health.
[FR Doc. 95-20313 Filed 8-15-95; 8:45 am]
BILLING CODE 4160-01-F